Cargando…
Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration
INTRODUCTION: Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease with limited therapeutic options and high lethality, related to alveolar type II epithelial (ATII) cell dysregulation, the abnormal repair of alveolar epithelial cells and activation of fibroblasts promote the develop...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632910/ https://www.ncbi.nlm.nih.gov/pubmed/37940355 http://dx.doi.org/10.1136/bmjresp-2022-001568 |
_version_ | 1785132672046071808 |
---|---|
author | Fu, Zhenli Yin, Hang Liu, Jiani He, Ying Song, Shengren Peng, Xiaomin Huang, Xihui Lai, Yunxin Li, Shuang Luo, Qun Su, Jin Yang, Penghui |
author_facet | Fu, Zhenli Yin, Hang Liu, Jiani He, Ying Song, Shengren Peng, Xiaomin Huang, Xihui Lai, Yunxin Li, Shuang Luo, Qun Su, Jin Yang, Penghui |
author_sort | Fu, Zhenli |
collection | PubMed |
description | INTRODUCTION: Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease with limited therapeutic options and high lethality, related to alveolar type II epithelial (ATII) cell dysregulation, the abnormal repair of alveolar epithelial cells and activation of fibroblasts promote the development of pulmonary fibrosis. Fatty acid binding protein 1 (FABP1) was significantly downregulated in the fibrotic state by proteomics screening in our previous date, and the ATII cell dysregulation can be mediated by FABP1 via regulating fatty acid metabolism and intracellular transport. The aim of this study was to evaluate the role and potential mechanism of FABP1 in the development of pulmonary fibrosis. METHODS: Proteomics screening was used to detect changes of the protein profiles in two different types (induced by bleomycin and silica, respectively) of pulmonary fibrosis models. The localisation of FABP1 in mouse lung was detected by Immunofluorescence and immunohistochemistry. Experimental methods such as lung pathology, micro-CT, western blotting, small animal imaging in vivo, EdU, etc were used to verify the role of FABP1 in pulmonary fibrosis. RESULTS: The expression of FABP1 in the mouse lung was significantly reduced in the model of pulmonary fibrosis from our proteomic analysis and immunological methods, the double immunofluorescence staining showed that FABP1 was mainly localised in type II alveolar epithelial cells. Additionally, the expression of FABP1 was negatively correlated with the progression of pulmonary fibrosis. Further in vivo and in vitro experiments showed that overexpression of FABP1 alleviated pulmonary fibrosis by protecting alveolar epithelium from injury and promoting cell survival. CONCLUSION: Our findings provide a proof-of-principle that FABP1 may represent an effective treatment for pulmonary fibrosis by regulating alveolar epithelial regeneration, which may be associated with the fatty acid metabolism in ATII cells. |
format | Online Article Text |
id | pubmed-10632910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-106329102023-11-10 Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration Fu, Zhenli Yin, Hang Liu, Jiani He, Ying Song, Shengren Peng, Xiaomin Huang, Xihui Lai, Yunxin Li, Shuang Luo, Qun Su, Jin Yang, Penghui BMJ Open Respir Res Interstitial Lung Disease INTRODUCTION: Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease with limited therapeutic options and high lethality, related to alveolar type II epithelial (ATII) cell dysregulation, the abnormal repair of alveolar epithelial cells and activation of fibroblasts promote the development of pulmonary fibrosis. Fatty acid binding protein 1 (FABP1) was significantly downregulated in the fibrotic state by proteomics screening in our previous date, and the ATII cell dysregulation can be mediated by FABP1 via regulating fatty acid metabolism and intracellular transport. The aim of this study was to evaluate the role and potential mechanism of FABP1 in the development of pulmonary fibrosis. METHODS: Proteomics screening was used to detect changes of the protein profiles in two different types (induced by bleomycin and silica, respectively) of pulmonary fibrosis models. The localisation of FABP1 in mouse lung was detected by Immunofluorescence and immunohistochemistry. Experimental methods such as lung pathology, micro-CT, western blotting, small animal imaging in vivo, EdU, etc were used to verify the role of FABP1 in pulmonary fibrosis. RESULTS: The expression of FABP1 in the mouse lung was significantly reduced in the model of pulmonary fibrosis from our proteomic analysis and immunological methods, the double immunofluorescence staining showed that FABP1 was mainly localised in type II alveolar epithelial cells. Additionally, the expression of FABP1 was negatively correlated with the progression of pulmonary fibrosis. Further in vivo and in vitro experiments showed that overexpression of FABP1 alleviated pulmonary fibrosis by protecting alveolar epithelium from injury and promoting cell survival. CONCLUSION: Our findings provide a proof-of-principle that FABP1 may represent an effective treatment for pulmonary fibrosis by regulating alveolar epithelial regeneration, which may be associated with the fatty acid metabolism in ATII cells. BMJ Publishing Group 2023-11-08 /pmc/articles/PMC10632910/ /pubmed/37940355 http://dx.doi.org/10.1136/bmjresp-2022-001568 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Interstitial Lung Disease Fu, Zhenli Yin, Hang Liu, Jiani He, Ying Song, Shengren Peng, Xiaomin Huang, Xihui Lai, Yunxin Li, Shuang Luo, Qun Su, Jin Yang, Penghui Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration |
title | Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration |
title_full | Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration |
title_fullStr | Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration |
title_full_unstemmed | Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration |
title_short | Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration |
title_sort | therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration |
topic | Interstitial Lung Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632910/ https://www.ncbi.nlm.nih.gov/pubmed/37940355 http://dx.doi.org/10.1136/bmjresp-2022-001568 |
work_keys_str_mv | AT fuzhenli therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT yinhang therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT liujiani therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT heying therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT songshengren therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT pengxiaomin therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT huangxihui therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT laiyunxin therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT lishuang therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT luoqun therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT sujin therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration AT yangpenghui therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration |